IDH1 and glioblastoma: The 2010 TCGA classified GBM into four expression subtypes—classical with EGFR amplification in 97%; mesenchymal associated with NF1 mutations; proneural strongly associated with PDGFRA amplification and IDH1 mutations inducing G‐CIMP hypermethylation; and neural.